-
1دورية أكاديمية
المؤلفون: Lippi BK; Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil., Fernandes GAB; Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil., Azevedo GA; Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil; Programa de Pós-Graduação em Medicina Translacional, Universidade Federal de São Paulo, São Paulo, SP, Brazil., Negreiros NGS; Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil., Soares AW; Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil; Programa de Pós-Graduação em Medicina Translacional, Universidade Federal de São Paulo, São Paulo, SP, Brazil., Landgraf MA; Universidade Paulista - campus Rangel, Santos, SP, Brazil., Fernandes JPS; Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil. Electronic address: joao.fernandes@unifesp.br., Landgraf RG; Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil. Electronic address: rglandgraf@unifesp.br.
المصدر: International immunopharmacology [Int Immunopharmacol] 2024 May 30; Vol. 133, pp. 112128. Date of Electronic Publication: 2024 Apr 22.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
مواضيع طبية MeSH: Benzofurans*/therapeutic use , Benzofurans*/pharmacology , Dextran Sulfate* , Piperazines*/pharmacology , Piperazines*/therapeutic use , Receptors, Histamine H4*/antagonists & inhibitors, Animals ; Male ; Mice ; Anti-Inflammatory Agents/therapeutic use ; Anti-Inflammatory Agents/pharmacology ; Colitis, Ulcerative/chemically induced ; Colitis, Ulcerative/drug therapy ; Colitis, Ulcerative/pathology ; Colon/pathology ; Colon/drug effects ; Cyclooxygenase 2/metabolism ; Disease Models, Animal ; Interleukin-6/metabolism ; Interleukin-6/blood ; Mice, Inbred BALB C ; NF-kappa B/metabolism ; STAT3 Transcription Factor/metabolism ; STAT3 Transcription Factor/antagonists & inhibitors